The patent claim is stated as a “method of increasing GLP-1 levels in a subject in need thereof, comprising administering a composition comprising eriocitrin to the subject.”
Ingredients by Nature (IBN; Montclair, CA) announced the approval by the U.S. Patent and Trademark Office (USPTO) of a second patent for its use of eriocitrin. The patent claim is stated as a “method of increasing GLP-1 levels in a subject in need thereof, comprising administering a composition comprising eriocitrin to the subject.”
GLP-1 helps maintain appropriate levels of insulin secretion and glucose uptake, solidifying the ingredient’s usage by people with poor blood sugar, such as prediabetics. According to Ingredients by Nature, administering 50-600 mg of the citrus flavonoid may help increase GLP-1 levels. IBN’s previous patent was recently amended to increase the dosage of eriocitrin from 100-200 mg to 25-800 mg for the lowering of blood sugar.
“There are multiple facets to prediabetes management and increasing GLP-1 plays a vital role in helping to support healthy blood glucose levels,” said Rob Brewster, president of IBN, in a press release. “The approval of our second eriocitrin patent provides strong support for our efforts to raise awareness of the flavonoid’s multi-faceted potential. We also have several more very promising human clinicals in process and hope to see some of them published soon.”
Eriocitrin is the primary citrus flavonoid used in IBN’s Eriomin ingredient, which is available in two version: Eriomin Glucose for the management of prediabetes, and Eriomin Esport for a healthy gaming lifestyle, which also helps maintain healthy blood glucose levels.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
Arla Foods to acquired whey nutrition business from Volac International
April 22nd 2024Arla Foods Ingredients has reached an agreement to acquire Volac’s Whey Nutrition business through a purchase of shares in Volac Whey Nutrition Holdings Limited and its subsidiary, Volac Whey Nutrition Limited and Volac Renewable Energy Limited.